Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic parameters in infective endocarditis: a prospective study.

R Agarwal1, V K Bahl, A N Malaviya

  • 1All India Institute of Medical Sciences, New Delhi.

Indian Heart Journal
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-resolved relaxation and fragmentation of polycyclic aromatic hydrocarbons investigated in the ultrafast XUV-IR regime.

Nature communications·2021
Same author

To Treat or Not to treat Asymptomatic Hyperuricemia.

The Journal of the Association of Physicians of India·2021
Same author

The human immunodeficiency virus and the healthcare worker.

The National medical journal of India·2018
Same author

Rheumatology-Specific Electronic Health Record Software: Comment on the Article by Newman et al.

Arthritis care & research·2015
Same author

Aspergillus vertebral osteomyelitis in immunocompetent patients.

Indian journal of orthopaedics·2012
Same author

Acute massive splenic infarction with complete liquefaction of the spleen in sickle cell disease.

Hematology/oncology and stem cell therapy·2011

Infective endocarditis involves elevated immunoglobulins and circulating immune complexes (CIC). Treatment reduced some immunoglobulin levels, while CIC levels varied with illness duration and rheumatoid factor presence.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cardiology

Background:

  • Infective endocarditis (IE) is a serious infection affecting heart valves.
  • The role of immune system components in IE pathogenesis and progression requires further elucidation.

Purpose of the Study:

  • To investigate the involvement of immunoglobulins (IgG, IgA, IgM), complement (C3), circulating immune complexes (CIC), heart antibodies (HAb), and rheumatoid factor (RF) in infective endocarditis.
  • To assess changes in these markers before and after therapy.

Main Methods:

  • Studied 28 infective endocarditis patients before and after treatment.
  • Measured serum levels of immunoglobulins, complement C3, CIC, and RF.
  • Analyzed CIC composition (IgG, IgA, IgM, C3) using 4% PEG precipitation.

Related Experiment Videos

Main Results:

  • Elevated IgG and IgA levels were observed before therapy compared to controls.
  • Treatment led to decreased IgA and IgM levels.
  • Lower C3 levels correlated with renal involvement.
  • Circulating immune complexes (CIC) were elevated in 64% of patients, with higher levels in shorter illness durations.
  • Initial CIC levels did not predict prognosis, but improvements in heart failure and clinical status were associated with specific CIC changes.
  • No significant overall change in CIC levels before and after therapy.
  • Rheumatoid factor presence influenced CIC and C3 responses to therapy.

Conclusions:

  • Immunoglobulins and CIC play a role in infective endocarditis.
  • Treatment modulates certain immune markers.
  • CIC dynamics are complex and related to disease duration and RF status.
  • Further research is needed to fully understand the prognostic and therapeutic implications of these immune markers in IE.